Fig. 3From: One-year outcomes of fixed-dosing Aflibercept therapy for pre treated and naive polypoidal choroidal vasculopathy patientFlowcharts of polyp regression assessed with indocyanine green angiography. a In the all patients b In the treatment-naïve group c In the pre-treated groupBack to article page